REGENTIS BIOMATERIALS LTD. (RGNT) — Institutional Holders, Q2 2026
6 institutional investment managers reported a RGNT position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $3.0M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
RGNT in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Rosalind AdvisorsAdded · +450,175 sh+$1.6M
- Warberg Asset ManagementNew · +86,980 sh+$307.0K
- JANE STREET GROUPNew · +43,333 sh+$153.0K
- RENAISSANCE TECHNOLOGIESNew · +13,348 sh+$47.1K
- UBS Group AGAdded · +100 sh+$353.00
Biggest sellers
- AIGH Capital ManagementSold out · -300,000 sh-$1.1M
RGNT 13F holders ranked 1–6 of 6
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Rosalind Advisors#1 · 701,685 sh | 701,685 | $2.5M | 0.65% | +179.0% |
| 2 | Warberg Asset Management#2 · 86,980 sh | 86,980 | $306.2K | 0.06% | New |
| 3 | JANE STREET GROUP#3 · 43,333 sh | 43,333 | $153.0K | 0.00% | New |
| 4 | RENAISSANCE TECHNOLOGIES#4 · 13,348 sh | 13,348 | $47.1K | <0.01% | New |
| 5 | UBS Group AG#5 · 434 sh | 434 | $1.5K | 0.00% | +29.9% |
| 6 | Tower Research Capital (TRC)#6 · 11 sh | 11 | $39.00 | 0.00% | New |
Funds that sold out of RGNT in Q2 2026 (1)
Held RGNT at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| AIGH Capital Management300,000 sh | 300,000 | $916.5K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.